Jonathan Miller

Jonathan Miller currently serves as the Head of Inflammation & Autoimmunity Global Product Strategy at Incyte, a position held since April 2025. Prior to this, Jonathan led Commercial Excellence at Ipsen, enhancing field force effectiveness and developing go-to-market strategies across multiple therapeutic areas. Jonathan's extensive career includes significant roles at Bristol Myers Squibb, overseeing the worldwide commercialization of Orencia, and at Celgene, where management of P&L for Hematology and Immunology units was achieved. Jonathan's experience spans various leadership positions in marketing and sales at companies such as Novartis and Biovail. Jonathan holds an MBA from the University of Maryland Global Campus and a Bachelor of Science in Marketing from West Virginia University.